Why the study?
What are the epidemiological, clinical, and biological parameters associated with neuroleptic malignant syndrome?
What are the epidemiological, clinical, and biological parameters associated with neuroleptic malignant syndrome?
This review highlights that the rate of neuroleptic loading is a critical factor in the development of neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
May support slower neuroleptic titration to lower NMS risk; leaves open prospective validation of loading rate.
This review comprises an exhaustive analysis of 120 case reports of neuroleptic malignant syndrome (NMS) representing the majority of published clinical data on this syndrome. Epidemiological, clinical and biological parameters, as well as those concerning the agent and the treatment of the syndrome, are critically evaluated on the basis of this data. The rate of neuroleptic loading is shown to play a cardinal role in the development of NMS. Rechallenge and aftercare of patients who need anti-psychotic treatment after NMS are considered.
No takes yet. Share an insight, caveat, or question.
Shalev et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: